Signals Research Suite offers integrated scientific data and workflow management aimed at streamlining workflows and helping clients make decisions on drug, compound, and formulation candidates, according to the vendor. It is available as a software as a service solution deployed on Amazon Web Services.

The new suite blends PerkinElmer Informatics' Signals Notebook electronic lab notebook; Signals VitroVivo 3.0 (formerly Signals Screening) data processing platform; and Signals Inventa 3.0 (formerly Signals Lead Discovery) data management, integration, and analytics platform. This combination enables data capture, search, publishing, and sharing; raw data conversion from other systems and sources; and visual analytics and predictive modeling, according to PerkinElmer.

PerkinElmer, Honeycomb launch single-cell isolation and analysis tool
PerkinElmer and Honeycomb Biotechnologies have launched a new single-cell isolation and analysis tool called Hive scRNAseq.

PerkinElmer acquires BioLegend for $5.25B
PerkinElmer announced it has completed its $5.25 billion acquisition of life science antibody and reagent company BioLegend, a deal first announced in...

PerkinElmer releases new KRAS investigation kits
PerkinElmer has released four new test kits designed to help researchers better understand KRAS protein structures and mutations. The kits will enable...

PerkinElmer posts growth in Q2
PerkinElmer posted revenue and operating income increases in its second quarter 2021.

PerkinElmer agrees to acquire Sirion Biotech
PerkinElmer has entered into an agreement to acquire Sirion Biotech, a provider of viral vector-based technology for cell and gene therapies. The acquisition...